Cargando…

Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification

Secondary AML (sAML), defined by either history of antecedent hematologic disease (AHD) or prior genotoxic therapy (tAML), is classically regarded as having worse prognosis than de novo disease (dnAML). Clinicians may infer a new AML diagnosis is secondary based on a history of antecedent blood coun...

Descripción completa

Detalles Bibliográficos
Autores principales: Hochman, Michael J., Othus, Megan, Hasserjian, Robert P., Ambinder, Alex, Brunner, Andrew, Percival, Mary-Elizabeth M., Hourigan, Christopher S., Swords, Ronan, DeZern, Amy E., Estey, Elihu H., Karp, Judith E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457181/
https://www.ncbi.nlm.nih.gov/pubmed/37524919
http://dx.doi.org/10.1038/s41375-023-01985-y